Business
Currency:CNY
2023/FY
Stock NameRevenueRatio
来自销售药品的收入69.92M80.22%
中国大陆独家推广许可权收入16.6M19.05%
提供合约服务的收入637K0.73%
Product
No Data
Region
Currency:CNY
2023/FY
Stock NameRevenueRatio
Chinese mainland87.16M100.00%